Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

FDA toxicity databases and real-time data entry.

Kirk B Arvidson1

  • 1Division of Food Contact Notifications, Office of Food Additive Safety, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, 5100 Paint Branch Parkway, HFS-275, College Park, MD 20740, USA. kirk.arvidson@fda.hhs.gov

Toxicology and Applied Pharmacology
|July 29, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thresholds of Toxicological Concern for cosmetics-related substances: New database, thresholds, and enrichment of chemical space.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2017
Same author

Regulatory use of computational toxicology tools and databases at the United States Food and Drug Administration's Office of Food Additive Safety.

Expert opinion on drug metabolism & toxicology·2010
Same author

A structural feature-based computational approach for toxicology predictions.

Expert opinion on drug metabolism & toxicology·2010
Same author

In silico toxicological screening of natural products.

Toxicology mechanisms and methods·2009
Same author

Testing computational toxicology models with phytochemicals.

Molecular nutrition & food research·2009
Same author

Computational toxicology approaches at the US Food and Drug Administration.

Alternatives to laboratory animals : ATLA·2009
Same journal

Corrigendum to 'Human-relevant exposure to mixtures of rare earth elements disrupts T3 homeostasis through impaired synthesis and conversion in human Thyrocytes' [Toxicology and Applied Pharmacology volume 514 (2026) 117929].

Toxicology and applied pharmacology·2026
Same journal

Per- and polyfluoroalkyl substances and the risk of thyroid and breast cancer: Evidence from a meta-analysis and computational toxicology.

Toxicology and applied pharmacology·2026
Same journal

High expression of Tbx15 in lung adenocarcinoma cells facilitates bone metastasis by suppressing IL-25 secretion and reducing MVP expression in osteoclasts.

Toxicology and applied pharmacology·2026
Same journal

Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657].

Toxicology and applied pharmacology·2026
Same journal

Time-resolved transcriptomic responses delineate liver injury, immune-mediated clearance, and regeneration following microcystin-LR exposure in whitefish: implications for an uptake-limiting defense response (autokleisis).

Toxicology and applied pharmacology·2026
Same journal

Ranolazine is associated with attenuation of lipopolysaccharide-induced acute kidney injury via modulation of inflammatory, oxidative, and vascular markers.

Toxicology and applied pharmacology·2026
See all related articles

The FDA is creating searchable databases of genetic toxicity data for food additives. This will speed up reviews and improve safety assessments by analyzing chemical structures and analogs.

Area of Science:

  • Toxicology
  • Computational Chemistry
  • Regulatory Science

Background:

  • Regulatory submissions for food additives contain valuable genetic toxicity data.
  • This data is currently fragmented across various formats, hindering efficient review.
  • Existing data management practices are paper-based and lack standardization.

Purpose of the Study:

  • To develop structure-searchable electronic databases for genetic toxicity data.
  • To consolidate and standardize historical and current toxicology information.
  • To enhance the efficiency and accuracy of regulatory reviews for food additives.

Main Methods:

  • Consolidation of genetic toxicity data from food additive petitions (1960s-present).
  • Development of four specialized database frameworks: bacterial mutagenesis, in vitro chromosome aberration, in vitro mammalian mutagenesis, and in vivo micronucleus.

More Related Videos

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Experiment Videos

Last Updated: Jul 3, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

  • Establishment of controlled vocabularies and compilation into a single, structurally-searchable database.

    • Main Results:

    • Creation of a unified, structure-searchable database for genetic toxicity information.
    • Identification of biologically active moieties and potential for Quantitative Structure-Activity Relationship (QSAR) modeling.
    • Facilitation of structural analog analysis for improved safety assessments.

    Conclusions:

    • Structure-searchable databases streamline regulatory review processes for food additives.
    • These databases enable advanced toxicological analysis, including QSAR and analog comparisons.
    • The initiative improves data accessibility for both regulatory agencies and industry.